C

Christopher Seaman

GlaxoSmithKline (United Kingdom)

Publishes on Health Systems, Economic Evaluations, Quality of Life, Animal testing and alternatives, Immunotoxicology and immune responses. 5 papers and 427 citations.

5Publications

427Total Citations

Health Systems, Economic Evaluations, Quality of Life Animal testing and alternatives Immunotoxicology and immune responses Meta-analysis and systematic reviews Carcinogens and Genotoxicity Assessment

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

A proposed eye irritation testing strategy to reduce and replace in vivo studies using Bottom–Up and Top–Down approaches

Laurie Scott, Chantra Eskes, Sebastian Hoffmann et al.|Toxicology in Vitro|2009

Cited by 213

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: A systematic review of the literature

Susan D. Ross, I. Elaine Allen, David H. Henry et al.|Clinical Therapeutics|2006

Cited by 115

A harmonization effort for acceptable daily exposure derivation – Considerations for application of adjustment factors

Robert Sussman, Bruce D. Naumann, Thomas D. Pfister et al.|Regulatory Toxicology and Pharmacology|2016

Cited by 52

Using default methodologies to derive an acceptable daily exposure (ADE)

Ellen C. Faria, Joel P. Bercu, David G. Dolan et al.|Regulatory Toxicology and Pharmacology|2016

Cited by 35

An evaluation of a cultured human corneal epithelial tissue model for the determination of the ocular irritation potential of pharmaceutical process materials

Christopher Seaman, Andrew Whittingham, Robert Guest et al.|Toxicology in Vitro|2010

Cited by 12